chr9-77728671-GA-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_002072.5(GNAQ):c.736-5del variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,295,286 control chromosomes in the GnomAD database, including 110 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 102 hom., cov: 0)
Exomes 𝑓: 0.031 ( 8 hom. )
Consequence
GNAQ
NM_002072.5 splice_region, splice_polypyrimidine_tract, intron
NM_002072.5 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.572
Genes affected
GNAQ (HGNC:4390): (G protein subunit alpha q) This locus encodes a guanine nucleotide-binding protein. The encoded protein, an alpha subunit in the Gq class, couples a seven-transmembrane domain receptor to activation of phospolipase C-beta. Mutations at this locus have been associated with problems in platelet activation and aggregation. A related pseudogene exists on chromosome 2.[provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-77728671-GA-G is Benign according to our data. Variant chr9-77728671-GA-G is described in ClinVar as [Benign]. Clinvar id is 776427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-77728671-GA-G is described in Lovd as [Benign]. Variant chr9-77728671-GA-G is described in Lovd as [Benign]. Variant chr9-77728671-GA-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0603 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAQ | NM_002072.5 | c.736-5del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000286548.9 | NP_002063.2 | |||
GNAQ | XM_047423239.1 | c.562-5del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_047279195.1 | ||||
GNAQ | XM_047423240.1 | c.562-5del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_047279196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAQ | ENST00000286548.9 | c.736-5del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_002072.5 | ENSP00000286548 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0183 AC: 2659AN: 145548Hom.: 102 Cov.: 0
GnomAD3 genomes
AF:
AC:
2659
AN:
145548
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0307 AC: 35312AN: 1149670Hom.: 8 Cov.: 22 AF XY: 0.0311 AC XY: 17934AN XY: 576428
GnomAD4 exome
AF:
AC:
35312
AN:
1149670
Hom.:
Cov.:
22
AF XY:
AC XY:
17934
AN XY:
576428
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0184 AC: 2673AN: 145616Hom.: 102 Cov.: 0 AF XY: 0.0176 AC XY: 1240AN XY: 70570
GnomAD4 genome
AF:
AC:
2673
AN:
145616
Hom.:
Cov.:
0
AF XY:
AC XY:
1240
AN XY:
70570
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 30, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at